The US tariff policy will cause a significant increase in drug prices in the United States.

According to a report released by the American Association of Drug Research Organizations and Pharmaceutical Manufacturers on April 22, reported by Reuters on April 25, the United States government's tariff policies will result in an increase of about $51 billion in import costs in the pharmaceutical field annually. These costs are likely to be passed on to American consumers, leading to an increase in drug prices by approximately 12.9%. In addition, the US government's tariff policies will also hamper the development of the US pharmaceutical industry, affect employment, and threaten the international competitiveness of the US pharmaceutical industry.